Please use this identifier to cite or link to this item: https://doi.org/10.14670/HH-30.173

Title: Tumor heterogeneity has important consequences for personalized medicine in ovarian cancer
Issue Date: 2015
Publisher: F. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de Biología Celular e Histología
Citation: Histology and Histopathology, Vol. 30, n.º 2 (2015)
ISSN: 1699-5848
0213-3911
Related subjects: CDU::5 - Ciencias puras y naturales::57 - Biología::576 - Biología celular y subcelular. Citología
CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología
Keywords: Tumor heterogeneity
Chemoresistance
Ovarian cancer
Personalized medicine
Abstract: Most patients with ovarian cancers relapse, and treatment failure has often been attributed to chemoresistance in tumor cells. Emerging evidence indicates that tumor heterogeneity may play an equally important role. Although the idea of tumor heterogeneity is not new, little attention has been focused on applying it to understand and control ovarian cancer progression. Recent advances in understanding its generation model, original basis, consequent problems, and derived therapies provide great potential for tumor heterogeneity to be a new insight in treatment of ovarian cancers.
Primary author: Gui, Ting
Cao, Dongyan
Yang, Jiaxin
Shen, Keng
URI: http://hdl.handle.net/10201/86563
DOI: https://doi.org/10.14670/HH-30.173
Document type: info:eu-repo/semantics/article
Number of pages / Extensions: 9
Rights: info:eu-repo/semantics/openAccess
Attribution-NonCommercial-NoDerivatives 4.0 International
Appears in Collections:Vol.30, nº2 (2015)

Files in This Item:
File Description SizeFormat 
Gui-30-173-181-2015.pdf166,43 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons